Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Plzen – page 6

187 clinical trials in Plzen, Czechia across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Plzen at a glance
187
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

187 trials in Plzen

Open in trial search

Cardiac failure

Recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Balcinrenone
  • Sponsor:AstraZeneca AB
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Emn Trial Office S.r.l. Impresa Sociale
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Rotigotine
  • Sponsor:Fondazione Santa Lucia
Countries:CzechiaCzechia
  • Participants:0–17 years
  • Substances:Budesonide
  • Sponsor:Novartis Pharma AG
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:CEEGOG z.s.

Atrial fibrillation

Not yet recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S

Hidradenitis

Not yet recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Avacopan
  • Sponsor:Amgen Inc.

Choroid melanoma

Not yet recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Belzupacap Sarotalocan
  • Sponsor:Aura Biosciences Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Janssen Cilag International

Autoimmune hepatitis

Not yet recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Inebilizumab
  • Sponsor:Amgen Inc.

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Plzen

What the registry says about research in the country

01 Hematologic Disorders

Groundbreaking research focusing on blood cancers and related conditions, including studies on innovative treatments for acute myeloid leukemia, chronic lymphocytic leukemia, and multiple myeloma. These trials are evaluating new therapeutic combinations and personalized treatment approaches.

  • Leukemia Treatment Studies
  • Multiple Myeloma Research
  • Myelodysplastic Syndrome Investigations
02 Respiratory Medicine

Clinical investigations targeting respiratory conditions, with particular emphasis on treatments for chronic obstructive pulmonary disease, asthma, and chronic rhinosinusitis. Research focuses on evaluating novel therapeutics and their effectiveness in managing symptoms.

  • COPD Management
  • Asthma Control Studies
  • Nasal Polyps Treatment
03 Mental Health

Innovative research addressing psychiatric disorders, including studies on generalized anxiety disorder and major depressive disorder. These trials are evaluating new therapeutic approaches and combination treatments to improve patient outcomes.

  • Anxiety Treatment Studies
  • Depression Management
  • Combination Therapy Research
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.